FDA: Other Drugs Contaminated with Meningitis

U.S. health officials have announced that two additional drugs produced by the Massachusetts pharmacy may be linked to the meningitis outbreak. FDA officials said a heart drug produced by the New England Compounding Center may have contributed to the contamination of three transplant patients. As of Monday, the total number of confirmed fungal meningitis cases has grown to 212. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm323946.htm?source=govdelivery